MedTrace Logo

Glycemic Control and Osteohealth in Adults Living With Type 1 Diabetes

NCT06158503 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2025-02-25

No results posted yet for this study

Summary

Bone damage is frequently observed in type 1 diabetes, and hyperglycemia is associated with an increased risk of fracture. This pilot study in 25 people living with type 1 diabetes aims to determine whether the introduction of an automated insulin delivery (AID) system improves bone markers through rapide optimization of glycemic control. Measurements will be taken before the start of AID, 2 months and 4 months afterwards.

Conditions

Interventions

DEVICE

AID

Initiation of an automated insulin delivery system

Sponsors & Collaborators

  • Laval University

    collaborator OTHER

  • Institut de Recherches Cliniques de Montreal

    collaborator OTHER

  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • Rémi Rabasa-Lhoret, MD, PhD · IRCM

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2026-12-31
Completion
2027-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06158503 on ClinicalTrials.gov